PAM
ELV icon

Pegasus Asset Management’s Elevance Health ELV Stock Holding History

Pegasus Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,656
Closed -$3.14M – 70
2023
Q4 		$3.14M Buy
6,656
+188
+3% +$86.9K 1.35% 32
2023
Q3 		$2.82M Buy
6,468
+77
+1% +$34.9K 1.31% 31
2023
Q2 		$2.84M Buy
6,391
+77
+1% +$35.5K 1.26% 33
2023
Q1 		$2.9M Buy
6,314
+63
+1% +$30K 1.44% 32
2022
Q4 		$3.21M Buy
6,251
+6
+0.1% +$3.05K 1.73% 21
2022
Q3 		$2.84M Buy
+6,245
New +$2.99M 1.6% 24

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pegasus Asset Management's ELV Position: Q1 2024 in Review

Pegasus Asset Management sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 6,656 shares — an estimated $3.14M sold.

Pegasus Asset Management first reported a position in ELV in Q3 2022 and held it in 6 quarters. The position peaked at $3.21M in Q4 2022. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • Pegasus Asset Management reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • Pegasus Asset Management sold 6,656 Elevance Health shares in Q1 2024, an estimated $3.14M.
  • Pegasus Asset Management first reported a position in Elevance Health in Q3 2022 and held it in 6 quarters.
  • Pegasus Asset Management's Elevance Health position peaked at $3.21M in Q4 2022.
  • 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Pegasus Asset Management's 13F filing for Q1 2024, filed 2 May 2024.